- Home
- UROY vs TKNO Comparison
UROY vs TKNO Comparison
Compare UROY & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UROY
- TKNO
- Stock Information
- Founded
- UROY 2017
- TKNO 1996
- Country
- UROY Canada
- TKNO United States
- Employees
- UROY N/A
- TKNO N/A
- Industry
- UROY
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- UROY
- TKNO Health Care
- Exchange
- UROY Nasdaq
- TKNO Nasdaq
- Market Cap
- UROY 336.8M
- TKNO 256.9M
- IPO Year
- UROY N/A
- TKNO 2021
- Fundamental
- Price
- UROY $3.15
- TKNO $4.35
- Analyst Decision
- UROY Strong Buy
- TKNO
- Analyst Count
- UROY 2
- TKNO 0
- Target Price
- UROY $4.00
- TKNO N/A
- AVG Volume (30 Days)
- UROY 2.6M
- TKNO 224.0K
- Earning Date
- UROY 07-16-2025
- TKNO 08-07-2025
- Dividend Yield
- UROY N/A
- TKNO N/A
- EPS Growth
- UROY N/A
- TKNO N/A
- EPS
- UROY N/A
- TKNO N/A
- Revenue
- UROY $11,285,840.00
- TKNO $38,923,000.00
- Revenue This Year
- UROY $228.36
- TKNO $9.52
- Revenue Next Year
- UROY N/A
- TKNO $15.20
- P/E Ratio
- UROY N/A
- TKNO N/A
- Revenue Growth
- UROY N/A
- TKNO 11.40
- 52 Week Low
- UROY $1.43
- TKNO $4.00
- 52 Week High
- UROY $3.30
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- UROY 65.88
- TKNO 43.35
- Support Level
- UROY $2.51
- TKNO $4.22
- Resistance Level
- UROY $2.87
- TKNO $4.94
- Average True Range (ATR)
- UROY 0.16
- TKNO 0.29
- MACD
- UROY 0.05
- TKNO -0.00
- Stochastic Oscillator
- UROY 82.05
- TKNO 16.75
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.